MedPath

Self Biophysical Profile Using a Home Ultrasound Device Proof of Concept

Not Applicable
Completed
Conditions
Perinatal Care
Registration Number
NCT06442358
Lead Sponsor
PulseNmore
Brief Summary

The objective of this study is to assess if patients presenting for antenatal testing can complete a Bio Physical Score (BPP) with a home-use ultrasound with remote clinician guidance.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
25
Inclusion Criteria
  • Age ≥ 18 years old
  • Singleton pregnancy
  • Gestational age ≥ 24 0/7 weeks
  • No known major fetal or genetic anomalies (may include: isolated pyelectasis, isolated --VSD, multicystic dysplastic kidney, cleft lip/palate, club foot, etc.)
  • Ability to understand and sign informed consent in English
  • Ability to read and understand instructions in English
  • Ability to hold an ultrasound probe and respond to clinician instructions
  • BMI less than 40 at initial prenatal visit
  • Scheduled biophysical profile (BPP)
  • Any maternal/pregnancy complications requiring antenatal testing, including but not limited to intrauterine growth restriction, chronic or gestational hypertension, preexisting or gestational diabetes, autoimmune disorder, etc.
Exclusion Criteria
  • Multiple gestation
  • Known major fetal structural anomaly or aneuploidy
  • Known fetal or genetic anomalies
  • Ruptured membranes
  • Uterine complaints, such as painful contractions
  • Maternal concern for decreased fetal movement
  • Not evaluated vaginal bleeding (not including spotting)
  • Fetal or maternal criteria that require urgent delivery
  • BMI ≥ 40 at initial prenatal visit

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Assess feasibility and proof of concept that the Pulsenmore home ultrasound device can be used to complete the biophysical profile (BPP) for fetal well beingOne day

Assessment will done by determining fetal movement, fetal tone, fetal breathing, and amniotic fluid level

Secondary Outcome Measures
NameTimeMethod
Assess preliminary effectiveness and compare participant results to standard of care BPPOne day

The results of BPP acquired with Pulsenmore device will be compared to standard of care BPP

Assess patient reported experience measures and patient reported outcomes with using the Pulsenmore home ultrasound device.One day

Patients will answer a questionnaire about their experience using Pulsenmore device

Trial Locations

Locations (1)

University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

University of Michigan
🇺🇸Ann Arbor, Michigan, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.